Metrics to compare | 6814 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6814PeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.0x | −99.3x | −0.2x | |
PEG Ratio | −2.59 | −10.86 | 0.00 | |
Price/Book | 4.3x | 8.3x | 2.6x | |
Price / LTM Sales | 4.9x | 170.7x | 2.6x | |
Upside (Analyst Target) | - | 0.0% | 76.9% | |
Fair Value Upside | Unlock | −12.9% | 14.9% | Unlock |
Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.